Imfinzi Plus Chemo Extends Survival in Advanced Small Cell Lung Cancer, Trial Analysis Shows
News
First-line treatment with Imfinzi (durvalumab) combined with standard chemotherapy significantly prolongs the life of people with extensive-stage small cell lung cancer (SCLC), final results of the CASPIAN Phase 3 trial ... Read more